Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan Sells 8,640 Shares of Stock

Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan sold 8,640 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $32.25, for a total value of $278,640.00. Following the transaction, the director now owns 71,576 shares of the company’s stock, valued at approximately $2,308,326. This trade represents a 10.77 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Kathleen Skarvan also recently made the following trade(s):

• On Tuesday, February 18th, Kathleen Skarvan sold 38,954 shares of Electromed stock. The stock was sold at an average price of $29.28, for a total transaction of $1,140,573.12.

Electromed Trading Down 0.6 %

NYSE ELMD opened at $29.36 on Thursday. Electromed, Inc. has a 12 month low of $13.74 and a 12 month high of $35.56. The stock has a market cap of $251.32 million, a PE ratio of 39.15 and a beta of 0.33. The stock’s 50 day moving average is $31.40 and its 200 day moving average is $25.15.

Analysts Set New Price Targets

Separately, StockNews.com cut Electromed from a “strong-buy” rating to a “buy” rating in a report on Wednesday.

Institutional Trading of Electromed

A number of large investors have recently added to or reduced their stakes in ELMD. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Electromed by 261.0% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 114,579 shares of the company’s stock worth $3,386,000 after purchasing an additional 82,839 shares during the period. Hunter Associates Investment Management LLC boosted its stake in shares of Electromed by 12.3% during the third quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock valued at $2,199,000 after purchasing an additional 11,250 shares during the period. Northern Trust Corp lifted its holdings in Electromed by 14.1% during the 4th quarter. Northern Trust Corp now owns 65,350 shares of the company’s stock valued at $1,931,000 after buying an additional 8,086 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Electromed during the fourth quarter worth approximately $1,760,000. Finally, Susquehanna International Group LLP boosted its holdings in shares of Electromed by 121.8% in the fourth quarter. Susquehanna International Group LLP now owns 56,726 shares of the company’s stock valued at $1,676,000 after purchasing an additional 31,148 shares during the period. Institutional investors own 40.82% of the company’s stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.